Back

UT-018, A Stem-Cell Chemoattractant Nutraceutical for intestinal Healing in DSS-Induced Colitis

Saxena, U.; Kambrath, S.; Kadiyala, G.; Gorantla, M.

2025-11-17 pharmacology and toxicology
10.1101/2025.11.17.688808 bioRxiv
Show abstract

We show here that UT-018, a proprietary nutraceutical designed to act as a stem-cell chemoattractant, protects against DSS-induced colitis in mice. UT-018 composed of amino acids and organic acid, promotes epithelial repair and mucosal regeneration by enhancing endogenous stem-cell migration and modulating inflammation. Treatment resulted in rapid recovery of body weight, reduced disease activity, and histological preservation of colonic mucosa. The effect was comparable to direct stem-cell delivery models reported elsewhere, achieved here through a safe, orally available formulation. UT-018 thus represents a new class of regenerative nutraceuticals that link metabolic signaling to mucosal healing.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.